Medexus Pharmaceuticals Net Income Over Time
| MDP Stock | 2.86 0.12 4.38% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medexus Pharmaceuticals Performance and Medexus Pharmaceuticals Correlation. Medexus |
Cross Equities Net Income Analysis
Compare Medexus Pharmaceuticals and related stocks such as Decibel Cannabis, and Cardiol Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DB | (1.4 M) | 1 M | (1.5 M) | (667.5 K) | (747.5 K) | (541.7 K) | (27 K) | (20.1 K) | (7.2 M) | (6.5 M) | (9.2 M) | 1.7 M | (4.5 M) | (1.8 M) | 9.5 M | 8.5 M | 8.9 M |
| CRDL | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (15.9 M) | (14 M) | (20.6 M) | (24.7 M) | (11.5 M) | (28.1 M) | (36.7 M) | (33 M) | (31.4 M) |
Medexus Pharmaceuticals and related stocks such as Decibel Cannabis, and Cardiol Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Medexus Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Medexus Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Medexus Pharmaceuticals | MDP |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 10 King Street |
| Exchange | Toronto Exchange |
null 2.86
Other Information on Investing in Medexus Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.